Financhill
Buy
52

BBH Quote, Financials, Valuation and Earnings

Last price:
$158.88
Seasonality move :
0.74%
Day range:
$158.04 - $159.77
52-week range:
$135.34 - $183.64
Dividend yield:
0.79%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
10.8K
Avg. volume:
9.6K
1-year change:
-10.02%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
BBH
VanEck Biotech ETF
-- -- -- -- --
FXH
First Trust Health Care AlphaDEX Fund
-- -- -- -- --
IHE
iShares US Pharmaceuticals ETF
-- -- -- -- --
IHF
iShares US Healthcare Providers ETF
-- -- -- -- --
PJP
Invesco Pharmaceuticals ETF
-- -- -- -- --
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
BBH
VanEck Biotech ETF
$158.22 -- -- -- $1.25 0.79% --
FXH
First Trust Health Care AlphaDEX Fund
$102.23 -- -- -- $0.06 0.34% --
IHE
iShares US Pharmaceuticals ETF
$67.18 -- -- -- $0.31 1.74% --
IHF
iShares US Healthcare Providers ETF
$45.22 -- -- -- $0.06 0.99% --
PJP
Invesco Pharmaceuticals ETF
$82.48 -- -- -- $0.27 1.17% --
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
$29.02 -- -- -- $0.06 0.77% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
BBH
VanEck Biotech ETF
-- 0.630 -- --
FXH
First Trust Health Care AlphaDEX Fund
-- 0.984 -- --
IHE
iShares US Pharmaceuticals ETF
-- 0.333 -- --
IHF
iShares US Healthcare Providers ETF
-- 0.813 -- --
PJP
Invesco Pharmaceuticals ETF
-- 0.248 -- --
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
-- 0.851 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
BBH
VanEck Biotech ETF
-- -- -- -- -- --
FXH
First Trust Health Care AlphaDEX Fund
-- -- -- -- -- --
IHE
iShares US Pharmaceuticals ETF
-- -- -- -- -- --
IHF
iShares US Healthcare Providers ETF
-- -- -- -- -- --
PJP
Invesco Pharmaceuticals ETF
-- -- -- -- -- --
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
-- -- -- -- -- --

VanEck Biotech ETF vs. Competitors

  • Which has Higher Returns BBH or FXH?

    First Trust Health Care AlphaDEX Fund has a net margin of -- compared to VanEck Biotech ETF's net margin of --. VanEck Biotech ETF's return on equity of -- beat First Trust Health Care AlphaDEX Fund's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    BBH
    VanEck Biotech ETF
    -- -- --
    FXH
    First Trust Health Care AlphaDEX Fund
    -- -- --
  • What do Analysts Say About BBH or FXH?

    VanEck Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Health Care AlphaDEX Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that VanEck Biotech ETF has higher upside potential than First Trust Health Care AlphaDEX Fund, analysts believe VanEck Biotech ETF is more attractive than First Trust Health Care AlphaDEX Fund.

    Company Buy Ratings Hold Ratings Sell Ratings
    BBH
    VanEck Biotech ETF
    0 0 0
    FXH
    First Trust Health Care AlphaDEX Fund
    0 0 0
  • Is BBH or FXH More Risky?

    VanEck Biotech ETF has a beta of 0.764, which suggesting that the stock is 23.586% less volatile than S&P 500. In comparison First Trust Health Care AlphaDEX Fund has a beta of 0.785, suggesting its less volatile than the S&P 500 by 21.471%.

  • Which is a Better Dividend Stock BBH or FXH?

    VanEck Biotech ETF has a quarterly dividend of $1.25 per share corresponding to a yield of 0.79%. First Trust Health Care AlphaDEX Fund offers a yield of 0.34% to investors and pays a quarterly dividend of $0.06 per share. VanEck Biotech ETF pays -- of its earnings as a dividend. First Trust Health Care AlphaDEX Fund pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BBH or FXH?

    VanEck Biotech ETF quarterly revenues are --, which are smaller than First Trust Health Care AlphaDEX Fund quarterly revenues of --. VanEck Biotech ETF's net income of -- is lower than First Trust Health Care AlphaDEX Fund's net income of --. Notably, VanEck Biotech ETF's price-to-earnings ratio is -- while First Trust Health Care AlphaDEX Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VanEck Biotech ETF is -- versus -- for First Trust Health Care AlphaDEX Fund. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BBH
    VanEck Biotech ETF
    -- -- -- --
    FXH
    First Trust Health Care AlphaDEX Fund
    -- -- -- --
  • Which has Higher Returns BBH or IHE?

    iShares US Pharmaceuticals ETF has a net margin of -- compared to VanEck Biotech ETF's net margin of --. VanEck Biotech ETF's return on equity of -- beat iShares US Pharmaceuticals ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    BBH
    VanEck Biotech ETF
    -- -- --
    IHE
    iShares US Pharmaceuticals ETF
    -- -- --
  • What do Analysts Say About BBH or IHE?

    VanEck Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that VanEck Biotech ETF has higher upside potential than iShares US Pharmaceuticals ETF, analysts believe VanEck Biotech ETF is more attractive than iShares US Pharmaceuticals ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    BBH
    VanEck Biotech ETF
    0 0 0
    IHE
    iShares US Pharmaceuticals ETF
    0 0 0
  • Is BBH or IHE More Risky?

    VanEck Biotech ETF has a beta of 0.764, which suggesting that the stock is 23.586% less volatile than S&P 500. In comparison iShares US Pharmaceuticals ETF has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.647%.

  • Which is a Better Dividend Stock BBH or IHE?

    VanEck Biotech ETF has a quarterly dividend of $1.25 per share corresponding to a yield of 0.79%. iShares US Pharmaceuticals ETF offers a yield of 1.74% to investors and pays a quarterly dividend of $0.31 per share. VanEck Biotech ETF pays -- of its earnings as a dividend. iShares US Pharmaceuticals ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BBH or IHE?

    VanEck Biotech ETF quarterly revenues are --, which are smaller than iShares US Pharmaceuticals ETF quarterly revenues of --. VanEck Biotech ETF's net income of -- is lower than iShares US Pharmaceuticals ETF's net income of --. Notably, VanEck Biotech ETF's price-to-earnings ratio is -- while iShares US Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VanEck Biotech ETF is -- versus -- for iShares US Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BBH
    VanEck Biotech ETF
    -- -- -- --
    IHE
    iShares US Pharmaceuticals ETF
    -- -- -- --
  • Which has Higher Returns BBH or IHF?

    iShares US Healthcare Providers ETF has a net margin of -- compared to VanEck Biotech ETF's net margin of --. VanEck Biotech ETF's return on equity of -- beat iShares US Healthcare Providers ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    BBH
    VanEck Biotech ETF
    -- -- --
    IHF
    iShares US Healthcare Providers ETF
    -- -- --
  • What do Analysts Say About BBH or IHF?

    VanEck Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare Providers ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that VanEck Biotech ETF has higher upside potential than iShares US Healthcare Providers ETF, analysts believe VanEck Biotech ETF is more attractive than iShares US Healthcare Providers ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    BBH
    VanEck Biotech ETF
    0 0 0
    IHF
    iShares US Healthcare Providers ETF
    0 0 0
  • Is BBH or IHF More Risky?

    VanEck Biotech ETF has a beta of 0.764, which suggesting that the stock is 23.586% less volatile than S&P 500. In comparison iShares US Healthcare Providers ETF has a beta of 0.729, suggesting its less volatile than the S&P 500 by 27.109%.

  • Which is a Better Dividend Stock BBH or IHF?

    VanEck Biotech ETF has a quarterly dividend of $1.25 per share corresponding to a yield of 0.79%. iShares US Healthcare Providers ETF offers a yield of 0.99% to investors and pays a quarterly dividend of $0.06 per share. VanEck Biotech ETF pays -- of its earnings as a dividend. iShares US Healthcare Providers ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BBH or IHF?

    VanEck Biotech ETF quarterly revenues are --, which are smaller than iShares US Healthcare Providers ETF quarterly revenues of --. VanEck Biotech ETF's net income of -- is lower than iShares US Healthcare Providers ETF's net income of --. Notably, VanEck Biotech ETF's price-to-earnings ratio is -- while iShares US Healthcare Providers ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VanEck Biotech ETF is -- versus -- for iShares US Healthcare Providers ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BBH
    VanEck Biotech ETF
    -- -- -- --
    IHF
    iShares US Healthcare Providers ETF
    -- -- -- --
  • Which has Higher Returns BBH or PJP?

    Invesco Pharmaceuticals ETF has a net margin of -- compared to VanEck Biotech ETF's net margin of --. VanEck Biotech ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    BBH
    VanEck Biotech ETF
    -- -- --
    PJP
    Invesco Pharmaceuticals ETF
    -- -- --
  • What do Analysts Say About BBH or PJP?

    VanEck Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that VanEck Biotech ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe VanEck Biotech ETF is more attractive than Invesco Pharmaceuticals ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    BBH
    VanEck Biotech ETF
    0 0 0
    PJP
    Invesco Pharmaceuticals ETF
    0 0 0
  • Is BBH or PJP More Risky?

    VanEck Biotech ETF has a beta of 0.764, which suggesting that the stock is 23.586% less volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.502, suggesting its less volatile than the S&P 500 by 49.771%.

  • Which is a Better Dividend Stock BBH or PJP?

    VanEck Biotech ETF has a quarterly dividend of $1.25 per share corresponding to a yield of 0.79%. Invesco Pharmaceuticals ETF offers a yield of 1.17% to investors and pays a quarterly dividend of $0.27 per share. VanEck Biotech ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BBH or PJP?

    VanEck Biotech ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. VanEck Biotech ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, VanEck Biotech ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VanEck Biotech ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BBH
    VanEck Biotech ETF
    -- -- -- --
    PJP
    Invesco Pharmaceuticals ETF
    -- -- -- --
  • Which has Higher Returns BBH or RSPH?

    Invesco S&P 500 Eql Wght Health Care ETF has a net margin of -- compared to VanEck Biotech ETF's net margin of --. VanEck Biotech ETF's return on equity of -- beat Invesco S&P 500 Eql Wght Health Care ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    BBH
    VanEck Biotech ETF
    -- -- --
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- --
  • What do Analysts Say About BBH or RSPH?

    VanEck Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P 500 Eql Wght Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that VanEck Biotech ETF has higher upside potential than Invesco S&P 500 Eql Wght Health Care ETF, analysts believe VanEck Biotech ETF is more attractive than Invesco S&P 500 Eql Wght Health Care ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    BBH
    VanEck Biotech ETF
    0 0 0
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    0 0 0
  • Is BBH or RSPH More Risky?

    VanEck Biotech ETF has a beta of 0.764, which suggesting that the stock is 23.586% less volatile than S&P 500. In comparison Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, suggesting its less volatile than the S&P 500 by 11.971%.

  • Which is a Better Dividend Stock BBH or RSPH?

    VanEck Biotech ETF has a quarterly dividend of $1.25 per share corresponding to a yield of 0.79%. Invesco S&P 500 Eql Wght Health Care ETF offers a yield of 0.77% to investors and pays a quarterly dividend of $0.06 per share. VanEck Biotech ETF pays -- of its earnings as a dividend. Invesco S&P 500 Eql Wght Health Care ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BBH or RSPH?

    VanEck Biotech ETF quarterly revenues are --, which are smaller than Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues of --. VanEck Biotech ETF's net income of -- is lower than Invesco S&P 500 Eql Wght Health Care ETF's net income of --. Notably, VanEck Biotech ETF's price-to-earnings ratio is -- while Invesco S&P 500 Eql Wght Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VanEck Biotech ETF is -- versus -- for Invesco S&P 500 Eql Wght Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BBH
    VanEck Biotech ETF
    -- -- -- --
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Will Microsoft Be a $5 Trillion Stock?
Will Microsoft Be a $5 Trillion Stock?

Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 14

MiNK Therapeutics [INKT] is down 35.61% over the past day.

Buy
51
NEGG alert for Jul 14

Newegg Commerce [NEGG] is down 25.73% over the past day.

Buy
68
ATRO alert for Jul 14

Astronics [ATRO] is down 2.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock